GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 45.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $264,000 | +33.3% | 107,203 | +24.4% | 0.01% | +40.0% |
| Q1 2017 | $198,000 | +138.6% | 86,195 | +1.9% | 0.01% | +150.0% |
| Q4 2016 | $83,000 | -27.2% | 84,603 | -16.2% | 0.00% | -33.3% |
| Q3 2016 | $114,000 | +660.0% | 100,958 | +867.3% | 0.00% | – |
| Q1 2016 | $15,000 | -75.4% | 10,437 | -72.1% | 0.00% | -100.0% |
| Q4 2015 | $61,000 | +74.3% | 37,364 | +153.3% | 0.00% | 0.0% |
| Q3 2015 | $35,000 | -80.9% | 14,750 | -78.0% | 0.00% | -66.7% |
| Q2 2015 | $183,000 | +32.6% | 67,133 | +68.6% | 0.00% | +50.0% |
| Q4 2014 | $138,000 | – | 39,823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |